HealthQuill Drugs
Women stand to benefit more than men when they indulge in physical activities as it lowers the risk of premature death or fatal cardiovascular events, according to a study conducted by the US-based National Institutes of Health.
Drugs Health Medical

Some HRT pills increase risk of heart disease, blood clots

Bharti Jayshankar November 29, 2024: Certain hormone replacement therapy (HRT) pills significantly elevate the risk of heart disease and serious blood clots in.

Read More
Israel’s Teva Pharmaceutical Industries, and US-based Launch Therapeutics, have joined hands to speed up the development of an experimental asthma drug.
Drugs Health

New treatment for severe asthma attacks in 50 years

Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of.

Read More
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Drugs Health Pharma

Roche to acquire US-based Poseida Therapeutics for $1.5 billion

Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.

Read More
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
Drugs Health Pharma

Cassava’s disputed Alzheimer’s drug flops in end-stage trials

Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.

Read More
Measles cases worldwide have risen 20% year-on-year in 2023 to about 10.3 million due to inadequate access to vaccines, according to new estimates from the World Health Organization.
Drugs Health Pharma

Measles cases surge worldwide, access to vaccine is ‘inadequate’: WHO

Measles cases worldwide have risen 20% year-on-year in 2023 to about 10.3 million due to inadequate access to vaccines, according to new estimates.

Read More
GLP-1 based weight-loss drugs have some therapeutic benefits, but the risks are as high
Drugs Health Pharma

Global diabetic population rose fourfold to 828 million in 2022

The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.

Read More
Novovax Inc., will soon start enrollment for end-stage trials of its Covid-19-Influenza vaccine and stand-alone influenza jab following a nod from the US drug regulator.
Drugs Health Pharma

US drug regulator removes clinical hold on Novavax’s vaccines

Novovax Inc., will soon start enrollment for end-stage trials of its Covid-19-Influenza vaccine and stand-alone influenza jab following a nod from the US.

Read More
Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of 2026, according to a company statement.
Drugs Health Pharma

AstraZeneca to invest $3.5 billion in the US to expand global footprint

Britain's AstraZeneca will invest $3.5 billion in the US, its largest market, to expand its research and manufacturing footprint by the end of.

Read More
AbbVie Inc.’s two mid-stage trials of an investigational schizophrenia drug have failed to meet its primary goal, according to a company statement.
Drugs Health Pharma

AbbVie says schizophrenic drug fails in 2 mid-stage experimental trials

AbbVie Inc.’s two mid-stage trials of an investigational schizophrenia drug have failed to meet its primary goal, according to a company statement.

Read More
The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency of international concern.
Drugs Health Pharma

WHO to convene emergency meeting on mpox on November 22

The World Health Organization will hold an emergency meeting on November 22 to decide whether mpox continues to be a public health emergency.

Read More